glp-1 and general anesthesia Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society for Perioperative Assessment Quality Improvement (SPAQI) multidisciplinary consensus statement Recommendations for the peri-operative management
Description
The most commonly cited symptoms include: Dry mouth (xerostomia) a persistent lack of saliva Rapid-onset cavities especially in patients with previously healthy teeth Gum inflammation and bleeding Bad breath (halitosis) Increased tooth sensitivity Changes in facial appearance related to significant weight loss (Ozempic face) Is this a real phenomenon

The result is a body that burns fewer calories and sends stronger hunger signals

Eligible subjects were randomised 1:1 to liraglutide 1.8 mg ( N = 26) once-daily subcutaneously or placebo ( N = 26) for 48 weeks

Neuroinflammation a common thread in neurological disorders

doi: 10.1186/1477-7827-9-39

Wearable devices can also help by keeping tabs on your daily activity and movement patterns
